Neratinib as extended adjuvant therapy in patients with copositive early breast cancer: German health technology assessment-driven analyses from the ExteNET study

DSpace Repository

Show simple item record

dc.contributor.author Hartkopf, Andreas
dc.date.accessioned 2021-11-22T09:34:30Z
dc.date.available 2021-11-22T09:34:30Z
dc.date.issued 2021
dc.identifier.issn 1879-0852
dc.identifier.uri http://hdl.handle.net/10900/120915
dc.language.iso en de_DE
dc.publisher Elsevier Sci Ltd de_DE
dc.relation.uri http://dx.doi.org/10.1016/j.ejca.2021.03.045 de_DE
dc.subject.ddc 610 de_DE
dc.title Neratinib as extended adjuvant therapy in patients with copositive early breast cancer: German health technology assessment-driven analyses from the ExteNET study de_DE
dc.type Artikel de_DE
utue.quellen.id 20210824232002_01021
utue.publikation.seiten 268-277 de_DE
utue.personen.roh Lueftner, Diana
utue.personen.roh Tesch, Hans
utue.personen.roh Schmidt, Marcus
utue.personen.roh Hartkopf, Andreas D.
utue.personen.roh Streicher, Sarah
utue.personen.roh Resch, Anna
utue.personen.roh Genovese, Luca
utue.personen.roh Rose, Christian
utue.personen.roh Valenti, Roberta
utue.personen.roh Harbeck, Nadia
dcterms.isPartOf.ZSTitelID European Journal of Cancer de_DE
dcterms.isPartOf.ZS-Volume 150 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record